US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Erasca, Inc.

15.16

-0.8300-5.19%

Pre-market: 15.240.0800+0.53%07:39 EDT

Volume:4.25M

Turnover:66.33M

Market Cap:4.70B

PE:-34.51

High:16.39

Open:15.89

Low:14.98

Close:15.99

52wk High:16.41

52wk Low:1.01

Shares:310.00M

Float Shares:223.00M

Volume Ratio:0.55

T/O Rate:1.91%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4393

EPS(LYR):-0.4393

ROE:-33.27%

ROA:-18.28%

PB:14.45

PE(LYR):-34.51

Loading ...

Overview Company News Filings

Erasca Inc - Initial Phase 1 Monotherapy Data for Eras-0015 Expected in H1 2026

THOMSON REUTERS

Erasca Inc - Exercises Option to Secure Worldwide Rights for Eras-0015

THOMSON REUTERS

Erasca expands ERAS-0015 license to secure worldwide rights including China, Hong Kong and Macau

Erasca Chief Medical Officer Morris Shannon Disposes of Common Shares

Erasca Is Maintained at Buy by Clear Street

Erasca price target raised to $20 from $11 at Clear Street

These stocks are set for high-stakes earnings moves. Here's your trading playbook.

Erasca, Tango Therapeutics Partner on Phase 1/2 Trial for Combination Cancer Therapy

MT Newswires Live

Tango Therapeutics Q4 net loss widens

BRIEF-Erasca And Tango Therapeutics Enter Into Clinical Collaboration To Evaluate Combination Of ERAS-0015 And Vopimetostat

Tango Therapeutics posts FY 2025 collaboration revenue of USD 62.4 million +108.2%

Erasca Inc: Co Will Supply Eras-0015 Free of Charge, and Tango Will Be Trial Sponsor

THOMSON REUTERS

Erasca Inc: Each Company Will Retain Commercial Rights to Their Respective Compound

THOMSON REUTERS

Erasca and Tango Therapeutics Enter Into Clinical Collaboration to Evaluate Combination of Eras-0015 and Vopimetostat

THOMSON REUTERS

Erasca Granted US Patent for Investigational Drug ERAS-4001 to Treat Solid Tumors

MT Newswires Live

Erasca announces issuance of U.S. patent covering ERAS-4001

Erasca Wins U.S. Patent for Pan-KRAS Inhibitor ERAS-4001 Through at Least 2043

Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001

Erasca to Present at Upcoming Conferences in February

Erasca CFO and CBO David M. Chacko Reports Acquisition of Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ERAS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ERAS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ERAS\",,,,,undefined,":{"symbol":"ERAS","market":"US","secType":"STK","nameCN":"Erasca, Inc.","latestPrice":15.16,"timestamp":1774555200000,"preClose":15.99,"halted":0,"volume":4252861,"hourTrading":{"tag":"盘前","latestPrice":15.24,"preClose":15.16,"latestTime":"07:39 EDT","volume":247,"amount":3763.809959,"timestamp":1774611566933,"change":0.08,"changeRate":0.005277,"amplitude":0.00066},"delay":0,"changeRate":-0.051907442151344595,"floatShares":223000000,"shares":310000000,"eps":-0.439263,"marketStatus":"Pre-Mkt","change":-0.83,"latestTime":"03-27 07:41:43 EDT","open":15.89,"high":16.39,"low":14.9801,"amount":66325506.484083004,"amplitude":0.088174,"askPrice":15.69,"askSize":25,"bidPrice":14.85,"bidSize":121,"shortable":3,"etf":0,"ttmEps":-0.439263,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774618200000},"marketStatusCode":1,"adr":0,"listingDate":1626408000000,"exchange":"NASDAQ","adjPreClose":15.16,"preHourTrading":{"tag":"盘前","latestPrice":15.24,"preClose":15.16,"latestTime":"07:39 EDT","volume":247,"amount":3763.809959,"timestamp":1774611566933,"change":0.08,"changeRate":0.005277,"amplitude":0.00066},"postHourTrading":{"tag":"盘后","latestPrice":15.4,"preClose":15.16,"latestTime":"19:19 EDT","volume":116617,"amount":1768373.4495,"timestamp":1774567192749,"change":0.24,"changeRate":0.015831,"amplitude":0.023747},"volumeRatio":0.5478304034861826,"impliedVol":1.0342,"impliedVolPercentile":0.48},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ERAS\",,,,,undefined,":{"symbol":"ERAS","floatShares":223000000,"roa":"-18.28%","roe":"-33.27%","lyrEps":-0.439263,"volumeRatio":0.5478304034861826,"shares":310000000,"dividePrice":0,"high":16.39,"amplitude":0.088174,"preClose":15.99,"low":14.9801,"week52Low":1.01,"pbRate":"14.45","week52High":16.405,"institutionHeld":0,"latestPrice":15.16,"committee":0.657534,"eps":-0.439263,"divideRate":0,"volume":4252861,"delay":0,"ttmEps":-0.439263,"open":15.89,"prevYearClose":3.72,"prevWeekClose":14.6,"prevMonthClose":13.66,"prevQuarterClose":3.72,"fiveDayClose":15.26,"twentyDayClose":13.57,"sixtyDayClose":3.46},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ERAS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-12","symbol":"ERAS","fiscalQuarterEnding":"2025/12","expectedEps":-0.11,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.1},{"market":"US","date":"2025-11-12","symbol":"ERAS","fiscalQuarterEnding":"2025/09","expectedEps":-0.11,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2025-08-12","symbol":"ERAS","fiscalQuarterEnding":"2025/06","expectedEps":-0.12,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.12},{"market":"US","date":"2025-05-13","symbol":"ERAS","fiscalQuarterEnding":"2025/03","expectedEps":-0.12,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2021-08-26","symbol":"ERAS","fiscalQuarterEnding":"2021/06","expectedEps":-0.2,"name":null,"time":"","type":"earning","dateTimestamp":1629950400000,"reportTimeType":"","actualEps":-1.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ERAS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ERAS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.0909,"sell":0.0909,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1768276800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ERAS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ERAS","date":"2026-03-25","current":-34.512354,"percent":0.006055,"low":-38.211613,"twenty":-8.563481,"median":-4.685822,"eighty":-1.856746,"high":-1.090479,"avg":-6.856485,"sd":7.315607,"marketCap":4559429354},"quantilePoints":[{"date":"2021-07-16","current":-21.083035,"twenty":-24.250523,"median":-12.685629,"eighty":-4.288223,"marketCap":2024371932},{"date":"2021-07-23","current":-23.687276,"twenty":-24.718019,"median":-23.687276,"eighty":-14.36511,"marketCap":2274428548},{"date":"2021-07-30","current":-26.01636,"twenty":-25.268079,"median":-23.755414,"eighty":-21.44591,"marketCap":2498064828},{"date":"2021-08-06","current":-26.003971,"twenty":-25.743807,"median":-24.678375,"eighty":-22.686799,"marketCap":2496875273},{"date":"2021-08-13","current":-24.876595,"twenty":-26.003971,"median":-24.777485,"eighty":-23.434546,"marketCap":2388625797},{"date":"2021-08-20","current":-25.979193,"twenty":-25.989104,"median":-24.777485,"eighty":-23.607988,"marketCap":2494496163},{"date":"2021-08-27","current":-23.490164,"twenty":-25.989104,"median":-24.777485,"eighty":-23.489721,"marketCap":2789269093},{"date":"2021-09-03","current":-24.347693,"twenty":-25.919727,"median":-24.678375,"eighty":-23.489721,"marketCap":2891093780},{"date":"2021-09-10","current":-21.458638,"twenty":-25.865217,"median":-24.347693,"eighty":-23.263532,"marketCap":2548041562},{"date":"2021-09-17","current":-19.82525,"twenty":-25.733896,"median":-24.096816,"eighty":-21.466805,"marketCap":2354089778},{"date":"2021-09-24","current":-19.641493,"twenty":-25.535677,"median":-23.885496,"eighty":-21.313675,"marketCap":2332270202},{"date":"2021-10-01","current":-22.009906,"twenty":-25.325068,"median":-23.755414,"eighty":-21.057263,"marketCap":2613500289},{"date":"2021-10-08","current":-17.732471,"twenty":-25.007916,"median":-23.489056,"eighty":-20.793032,"marketCap":2105589055},{"date":"2021-10-15","current":-18.171444,"twenty":-24.888984,"median":-23.280887,"eighty":-20.311182,"marketCap":2157713597},{"date":"2021-10-22","current":-19.28419,"twenty":-24.884028,"median":-22.867435,"eighty":-19.694579,"marketCap":2289843249},{"date":"2021-10-29","current":-20.192762,"twenty":-24.865124,"median":-21.848866,"eighty":-19.64966,"marketCap":2397728929},{"date":"2021-11-05","current":-20.223388,"twenty":-24.819745,"median":-21.530098,"eighty":-19.665994,"marketCap":2401365525},{"date":"2021-11-12","current":-15.293605,"twenty":-24.777485,"median":-21.448429,"eighty":-19.55574,"marketCap":2358319793},{"date":"2021-11-19","current":-14.177054,"twenty":-24.737841,"median":-21.264673,"eighty":-18.89626,"marketCap":2186144261},{"date":"2021-11-26","current":-12.061897,"twenty":-24.624489,"median":-21.040082,"eighty":-18.40216,"marketCap":1859980752},{"date":"2021-12-03","current":-11.118333,"twenty":-24.396695,"median":-20.728717,"eighty":-17.626301,"marketCap":1714480302},{"date":"2021-12-10","current":-10.937483,"twenty":-24.34693,"median":-20.621526,"eighty":-15.403688,"marketCap":1686592716},{"date":"2021-12-17","current":-11.684472,"twenty":-24.311668,"median":-20.325474,"eighty":-14.428671,"marketCap":1801780572},{"date":"2021-12-23","current":-11.417128,"twenty":-24.182826,"median":-20.208075,"eighty":-12.942557,"marketCap":1760555445},{"date":"2021-12-31","current":-12.25061,"twenty":-24.010807,"median":-20.121301,"eighty":-11.936089,"marketCap":1889080842},{"date":"2022-01-07","current":-10.135453,"twenty":-23.935051,"median":-19.937545,"eighty":-11.684472,"marketCap":1562917333},{"date":"2022-01-14","current":-10.174769,"twenty":-23.885496,"median":-19.82525,"eighty":-11.417128,"marketCap":1568979852},{"date":"2022-01-21","current":-8.688655,"twenty":-23.875585,"median":-19.672119,"eighty":-11.179664,"marketCap":1339816643},{"date":"2022-01-28","current":-8.845916,"twenty":-23.833463,"median":-19.570032,"eighty":-10.998814,"marketCap":1364066718},{"date":"2022-02-04","current":-9.003176,"twenty":-23.714531,"median":-19.273981,"eighty":-10.904458,"marketCap":1388316793},{"date":"2022-02-11","current":-9.632219,"twenty":-23.529586,"median":-18.7074,"eighty":-10.509734,"marketCap":1485317093},{"date":"2022-02-18","current":-9.066081,"twenty":-23.489278,"median":-18.396035,"eighty":-10.199931,"marketCap":1398016823},{"date":"2022-02-25","current":-9.553589,"twenty":-23.40729,"median":-18.171444,"eighty":-9.855529,"marketCap":1473192056},{"date":"2022-03-04","current":-8.877368,"twenty":-23.343332,"median":-17.467045,"eighty":-9.754883,"marketCap":1368916733},{"date":"2022-03-11","current":-8.948135,"twenty":-23.269657,"median":-15.529496,"eighty":-9.563025,"marketCap":1379829267},{"date":"2022-03-18","current":-8.853779,"twenty":-23.218614,"median":-15.10096,"eighty":-9.430925,"marketCap":1365279222},{"date":"2022-03-25","current":-9.696562,"twenty":-23.006273,"median":-14.326452,"eighty":-9.364876,"marketCap":1190388793},{"date":"2022-04-01","current":-8.369352,"twenty":-22.702055,"median":-13.123407,"eighty":-9.35544,"marketCap":1027455087},{"date":"2022-04-08","current":-8.002883,"twenty":-22.242664,"median":-12.25061,"eighty":-9.24064,"marketCap":982465929},{"date":"2022-04-14","current":-8.547634,"twenty":-21.881074,"median":-12.061897,"eighty":-9.069226,"marketCap":1049341704},{"date":"2022-04-22","current":-8.022692,"twenty":-21.677821,"median":-11.822075,"eighty":-8.99374,"marketCap":984897775},{"date":"2022-04-29","current":-7.210518,"twenty":-21.609726,"median":-11.574389,"eighty":-8.900741,"marketCap":885192075},{"date":"2022-05-06","current":-6.903477,"twenty":-21.509681,"median":-11.428922,"eighty":-8.860069,"marketCap":847498456},{"date":"2022-05-13","current":-5.005309,"twenty":-21.470888,"median":-11.244142,"eighty":-8.740551,"marketCap":706774689},{"date":"2022-05-20","current":-4.98805,"twenty":-21.450471,"median":-11.157648,"eighty":-8.644946,"marketCap":704337534},{"date":"2022-05-27","current":-4.841342,"twenty":-21.417803,"median":-11.00825,"eighty":-8.555558,"marketCap":683621725},{"date":"2022-06-03","current":-4.875862,"twenty":-21.362676,"median":-10.937483,"eighty":-8.502073,"marketCap":688496033},{"date":"2022-06-10","current":-4.642856,"twenty":-21.228345,"median":-10.878511,"eighty":-8.23465,"marketCap":655594452},{"date":"2022-06-17","current":-4.254513,"twenty":-21.074444,"median":-10.575783,"eighty":-8.0841,"marketCap":600758485},{"date":"2022-06-24","current":-5.117497,"twenty":-21.040082,"median":-10.497153,"eighty":-8.002883,"marketCap":722616190},{"date":"2022-07-01","current":-5.022569,"twenty":-20.866535,"median":-10.273056,"eighty":-7.834506,"marketCap":709211843},{"date":"2022-07-08","current":-5.781995,"twenty":-20.768531,"median":-10.155111,"eighty":-7.607209,"marketCap":816446623},{"date":"2022-07-15","current":-5.738846,"twenty":-20.719529,"median":-9.836658,"eighty":-7.179043,"marketCap":810353738},{"date":"2022-07-22","current":-6.446493,"twenty":-20.705238,"median":-9.769823,"eighty":-6.653609,"marketCap":910277056},{"date":"2022-07-29","current":-6.506902,"twenty":-20.63786,"median":-9.718713,"eighty":-6.665691,"marketCap":918807095},{"date":"2022-08-05","current":-7.73234,"twenty":-20.458188,"median":-9.61982,"eighty":-6.499998,"marketCap":1091845036},{"date":"2022-08-12","current":-8.03085,"twenty":-20.401019,"median":-9.553589,"eighty":-6.64498,"marketCap":1193376219},{"date":"2022-08-19","current":-6.986921,"twenty":-20.282598,"median":-9.510343,"eighty":-6.70021,"marketCap":1038249525},{"date":"2022-08-26","current":-6.871843,"twenty":-20.229513,"median":-9.412054,"eighty":-6.760619,"marketCap":1021148945},{"date":"2022-09-02","current":-7.266398,"twenty":-20.198887,"median":-9.364876,"eighty":-6.77156,"marketCap":1079779506},{"date":"2022-09-09","current":-6.986921,"twenty":-20.162136,"median":-9.353082,"eighty":-6.773938,"marketCap":1038249525},{"date":"2022-09-16","current":-6.674565,"twenty":-20.129468,"median":-9.317698,"eighty":-6.773938,"marketCap":991833664},{"date":"2022-09-23","current":-6.23069,"twenty":-20.109051,"median":-9.156506,"eighty":-6.677525,"marketCap":925874282},{"date":"2022-09-30","current":-6.411528,"twenty":-20.027382,"median":-9.066081,"eighty":-6.501632,"marketCap":952746623},{"date":"2022-10-07","current":-6.485507,"twenty":-19.929378,"median":-9.018902,"eighty":-6.501632,"marketCap":963739853},{"date":"2022-10-14","current":-5.877234,"twenty":-19.878334,"median":-8.971724,"eighty":-6.432507,"marketCap":873351071},{"date":"2022-10-21","current":-6.156711,"twenty":-19.841584,"median":-8.904619,"eighty":-6.242142,"marketCap":914881052},{"date":"2022-10-28","current":-6.567706,"twenty":-19.776248,"median":-8.877368,"eighty":-6.207216,"marketCap":975954553},{"date":"2022-11-04","current":-5.597757,"twenty":-19.700703,"median":-8.849847,"eighty":-6.176438,"marketCap":831821090},{"date":"2022-11-11","current":-7.455939,"twenty":-19.665994,"median":-8.767285,"eighty":-6.137501,"marketCap":1029061190},{"date":"2022-11-18","current":-6.986064,"twenty":-19.64966,"median":-8.708312,"eighty":-6.153423,"marketCap":964209534},{"date":"2022-11-25","current":-6.21476,"twenty":-19.584325,"median":-8.668997,"eighty":-6.169863,"marketCap":857754928},{"date":"2022-12-02","current":-6.746694,"twenty":-19.412819,"median":-8.625751,"eighty":-6.169863,"marketCap":931171897},{"date":"2022-12-09","current":-6.175282,"twenty":-19.280106,"median":-8.557538,"eighty":-6.181005,"marketCap":852306288},{"date":"2022-12-16","current":-4.946749,"twenty":-19.122893,"median":-8.51792,"eighty":-6.107909,"marketCap":682745354},{"date":"2022-12-23","current":-4.45751,"twenty":-18.89626,"median":-8.399414,"eighty":-6.025192,"marketCap":615221088},{"date":"2022-12-30","current":-4.685822,"twenty":-18.820716,"median":-8.296796,"eighty":-6.000532,"marketCap":646732412},{"date":"2023-01-06","current":-4.490126,"twenty":-18.518539,"median":-8.199663,"eighty":-5.959433,"marketCap":619722706},{"date":"2023-01-13","current":-4.522742,"twenty":-18.426661,"median":-8.181165,"eighty":-5.901894,"marketCap":624224323},{"date":"2023-01-20","current":-4.174839,"twenty":-18.40216,"median":-8.092024,"eighty":-5.815606,"marketCap":576207068},{"date":"2023-01-27","current":-4.392278,"twenty":-18.273531,"median":-8.051533,"eighty":-5.735288,"marketCap":606217852},{"date":"2023-02-03","current":-4.72931,"twenty":-18.185736,"median":-8.002883,"eighty":-5.577009,"marketCap":652734569},{"date":"2023-02-10","current":-4.240071,"twenty":-17.820266,"median":-7.940354,"eighty":-5.359884,"marketCap":585210303},{"date":"2023-02-17","current":-4.229199,"twenty":-17.626301,"median":-7.854315,"eighty":-5.255566,"marketCap":583709764},{"date":"2023-02-24","current":-3.903039,"twenty":-17.440502,"median":-7.834506,"eighty":-5.148564,"marketCap":538693587},{"date":"2023-03-03","current":-3.805192,"twenty":-16.374094,"median":-7.729527,"eighty":-4.998405,"marketCap":525188734},{"date":"2023-03-10","current":-3.315953,"twenty":-15.611272,"median":-7.554095,"eighty":-4.946009,"marketCap":457664468},{"date":"2023-03-17","current":-3.326825,"twenty":-15.43514,"median":-7.482536,"eighty":-4.840017,"marketCap":459165007},{"date":"2023-03-24","current":-1.755181,"twenty":-15.325057,"median":-7.397917,"eighty":-4.803371,"marketCap":426166819},{"date":"2023-03-31","current":-1.866818,"twenty":-15.062432,"median":-7.367014,"eighty":-4.767125,"marketCap":453272835},{"date":"2023-04-06","current":-1.829606,"twenty":-14.880009,"median":-7.312641,"eighty":-4.729216,"marketCap":444237496},{"date":"2023-04-14","current":-1.922637,"twenty":-14.63311,"median":-7.266398,"eighty":-4.672197,"marketCap":466825844},{"date":"2023-04-21","current":-1.742777,"twenty":-14.266693,"median":-7.201469,"eighty":-4.63602,"marketCap":423155039},{"date":"2023-04-28","current":-1.618736,"twenty":-13.827935,"median":-7.11022,"eighty":-4.570579,"marketCap":393037243},{"date":"2023-05-05","current":-1.775609,"twenty":-13.159577,"median":-7.043207,"eighty":-4.498824,"marketCap":431126630},{"date":"2023-05-12","current":-1.868735,"twenty":-12.801023,"median":-6.986921,"eighty":-4.424894,"marketCap":453738166},{"date":"2023-05-19","current":-1.736837,"twenty":-12.453477,"median":-6.986492,"eighty":-4.353139,"marketCap":416052272},{"date":"2023-05-26","current":-1.862855,"twenty":-12.219158,"median":-6.962262,"eighty":-4.322577,"marketCap":446239467},{"date":"2023-06-02","current":-1.692932,"twenty":-12.149963,"median":-6.906274,"eighty":-4.3055,"marketCap":405535192},{"date":"2023-06-09","current":-1.711813,"twenty":-12.036735,"median":-6.870599,"eighty":-4.284491,"marketCap":410057889},{"date":"2023-06-16","current":-1.74328,"twenty":-11.926653,"median":-6.855403,"eighty":-4.242245,"marketCap":417595718},{"date":"2023-06-23","current":-1.674052,"twenty":-11.888911,"median":-6.808947,"eighty":-4.229199,"marketCap":401012494},{"date":"2023-06-30","current":-1.680346,"twenty":-11.781973,"median":-6.774427,"eighty":-4.190251,"marketCap":402520060},{"date":"2023-07-07","current":-1.686639,"twenty":-11.712779,"median":-6.764984,"eighty":-4.163967,"marketCap":404027626},{"date":"2023-07-14","current":-1.705519,"twenty":-11.618422,"median":-6.722313,"eighty":-4.063945,"marketCap":408550323},{"date":"2023-07-21","current":-1.642585,"twenty":-11.536647,"median":-6.6935,"eighty":-3.913911,"marketCap":393474665},{"date":"2023-07-28","current":-1.56077,"twenty":-11.469024,"median":-6.677032,"eighty":-3.850854,"marketCap":373876310},{"date":"2023-08-04","current":-1.629998,"twenty":-11.426564,"median":-6.649172,"eighty":-3.700821,"marketCap":390459534},{"date":"2023-08-11","current":-1.658751,"twenty":-11.384103,"median":-6.54638,"eighty":-3.50295,"marketCap":390999078},{"date":"2023-08-18","current":-1.601332,"twenty":-11.29132,"median":-6.506902,"eighty":-3.322476,"marketCap":377464495},{"date":"2023-08-25","current":-1.645991,"twenty":-11.206399,"median":-6.483117,"eighty":-2.72898,"marketCap":387991393},{"date":"2023-09-01","current":-1.652371,"twenty":-11.176519,"median":-6.45413,"eighty":-1.916346,"marketCap":389495235},{"date":"2023-09-08","current":-1.665131,"twenty":-11.160793,"median":-6.411528,"eighty":-1.887628,"marketCap":392502921},{"date":"2023-09-15","current":-1.658751,"twenty":-11.132486,"median":-6.312281,"eighty":-1.866818,"marketCap":390999078},{"date":"2023-09-22","current":-1.505635,"twenty":-11.0743,"median":-6.25535,"eighty":-1.861447,"marketCap":354906855},{"date":"2023-09-29","current":-1.288722,"twenty":-10.989379,"median":-6.22658,"eighty":-1.848995,"marketCap":303776207},{"date":"2023-10-06","current":-1.35252,"twenty":-10.951636,"median":-6.21476,"eighty":-1.830319,"marketCap":318814633},{"date":"2023-10-13","current":-1.531155,"twenty":-10.937483,"median":-6.201852,"eighty":-1.812554,"marketCap":360922226},{"date":"2023-10-20","current":-1.422698,"twenty":-10.931193,"median":-6.175282,"eighty":-1.791839,"marketCap":335356902},{"date":"2023-10-27","current":-1.371659,"twenty":-10.924902,"median":-6.156711,"eighty":-1.786107,"marketCap":323326161},{"date":"2023-11-03","current":-1.499256,"twenty":-10.852563,"median":-6.110094,"eighty":-1.775245,"marketCap":353403013},{"date":"2023-11-10","current":-1.312493,"twenty":-10.753488,"median":-6.066292,"eighty":-1.764019,"marketCap":302649060},{"date":"2023-11-17","current":-1.449619,"twenty":-10.607235,"median":-6.012862,"eighty":-1.750535,"marketCap":334269111},{"date":"2023-11-24","current":-1.521447,"twenty":-10.538041,"median":-6.000532,"eighty":-1.741009,"marketCap":350831995},{"date":"2023-12-01","current":-1.110069,"twenty":-10.503443,"median":-5.97539,"eighty":-1.736926,"marketCap":255971842},{"date":"2023-12-08","current":-1.208016,"twenty":-10.449975,"median":-5.948588,"eighty":-1.727984,"marketCap":278557593},{"date":"2023-12-15","current":-1.273314,"twenty":-10.371344,"median":-5.901894,"eighty":-1.71284,"marketCap":293614760},{"date":"2023-12-22","current":-1.273314,"twenty":-10.259689,"median":-5.823804,"eighty":-1.705519,"marketCap":293614760},{"date":"2023-12-29","current":-1.436559,"twenty":-10.199931,"median":-5.799255,"eighty":-1.700594,"marketCap":331257678},{"date":"2024-01-05","current":-1.41044,"twenty":-10.181059,"median":-5.776185,"eighty":-1.692932,"marketCap":325234811},{"date":"2024-01-12","current":-1.273314,"twenty":-10.143316,"median":-5.721056,"eighty":-1.686639,"marketCap":293614760},{"date":"2024-01-19","current":-1.162307,"twenty":-9.975047,"median":-5.597757,"eighty":-1.67789,"marketCap":268017576},{"date":"2024-01-26","current":-1.129658,"twenty":-9.849239,"median":-5.484266,"eighty":-1.673035,"marketCap":260488992},{"date":"2024-02-02","current":-1.123128,"twenty":-9.822505,"median":-5.359884,"eighty":-1.665131,"marketCap":258983275},{"date":"2024-02-09","current":-1.149248,"twenty":-9.794198,"median":-5.320298,"eighty":-1.658751,"marketCap":265006142},{"date":"2024-02-16","current":-1.168837,"twenty":-9.767464,"median":-5.229685,"eighty":-1.655172,"marketCap":269523292},{"date":"2024-02-23","current":-1.292903,"twenty":-9.754883,"median":-5.169276,"eighty":-1.650275,"marketCap":298131910},{"date":"2024-03-01","current":-1.554096,"twenty":-9.737584,"median":-5.018254,"eighty":-1.647146,"marketCap":358360579},{"date":"2024-03-08","current":-1.40391,"twenty":-9.709853,"median":-4.98805,"eighty":-1.644077,"marketCap":323729094},{"date":"2024-03-15","current":-1.358202,"twenty":-9.670825,"median":-4.958769,"eighty":-1.639611,"marketCap":313189077},{"date":"2024-03-22","current":-1.40391,"twenty":-9.6223,"median":-4.875862,"eighty":-1.629998,"marketCap":323729094},{"date":"2024-03-28","current":-2.489659,"twenty":-9.5998,"median":-4.841342,"eighty":-1.6243,"marketCap":311311907},{"date":"2024-04-05","current":-2.525916,"twenty":-9.56617,"median":-4.81699,"eighty":-1.627481,"marketCap":315845575},{"date":"2024-04-12","current":-2.76763,"twenty":-9.550489,"median":-4.798193,"eighty":-1.629998,"marketCap":346070032},{"date":"2024-04-19","current":-2.163344,"twenty":-9.536472,"median":-4.780933,"eighty":-1.629998,"marketCap":270508890},{"date":"2024-04-26","current":-2.272116,"twenty":-9.522137,"median":-4.737784,"eighty":-1.631257,"marketCap":284109895},{"date":"2024-05-03","current":-2.59843,"twenty":-9.481249,"median":-4.723796,"eighty":-1.636956,"marketCap":324912912},{"date":"2024-05-10","current":-2.674583,"twenty":-9.437216,"median":-4.677375,"eighty":-1.639611,"marketCap":339297652},{"date":"2024-05-17","current":-2.524479,"twenty":-9.405764,"median":-4.652346,"eighty":-1.640206,"marketCap":320255436},{"date":"2024-05-24","current":-5.564856,"twenty":-9.377457,"median":-4.653206,"eighty":-1.642585,"marketCap":705957607},{"date":"2024-05-31","current":-5.328511,"twenty":-9.364876,"median":-4.677375,"eighty":-1.642585,"marketCap":675974852},{"date":"2024-06-07","current":-5.059936,"twenty":-9.364876,"median":-4.723796,"eighty":-1.642801,"marketCap":641903539},{"date":"2024-06-14","current":-4.683933,"twenty":-9.364876,"median":-4.729232,"eighty":-1.645353,"marketCap":594203700},{"date":"2024-06-21","current":-4.361644,"twenty":-9.350723,"median":-4.70213,"eighty":-1.645991,"marketCap":553318125},{"date":"2024-06-28","current":-4.96325,"twenty":-9.341287,"median":-4.723796,"eighty":-1.645991,"marketCap":629637866},{"date":"2024-07-05","current":-4.683933,"twenty":-9.328706,"median":-4.723796,"eighty":-1.645991,"marketCap":594203700},{"date":"2024-07-12","current":-6.037546,"twenty":-9.319271,"median":-4.72931,"eighty":-1.648301,"marketCap":765923119},{"date":"2024-07-15","current":-6.381321,"twenty":-9.317698,"median":-4.733547,"eighty":-1.648878,"marketCap":809534399},{"date":"2024-08-02","current":-6.59618,"twenty":-9.30669,"median":-4.737784,"eighty":-1.648878,"marketCap":836791450},{"date":"2024-08-09","current":-5.349997,"twenty":-9.251648,"median":-4.769876,"eighty":-1.648878,"marketCap":678700557},{"date":"2024-08-16","current":-4.834791,"twenty":-9.187171,"median":-4.769876,"eighty":-1.648878,"marketCap":765250767},{"date":"2024-08-23","current":-4.888313,"twenty":-9.099106,"median":-4.780933,"eighty":-1.649577,"marketCap":773722178},{"date":"2024-08-30","current":-5.013197,"twenty":-9.072371,"median":-4.798193,"eighty":-1.652371,"marketCap":793488803},{"date":"2024-09-06","current":-5.334327,"twenty":-9.066081,"median":-4.806823,"eighty":-1.652371,"marketCap":844317267},{"date":"2024-09-13","current":-5.459211,"twenty":-9.042862,"median":-4.83641,"eighty":-1.655172,"marketCap":864083892},{"date":"2024-09-20","current":-5.298646,"twenty":-9.034628,"median":-4.841342,"eighty":-1.655172,"marketCap":838669660},{"date":"2024-09-27","current":-4.834791,"twenty":-9.003176,"median":-4.841342,"eighty":-1.655172,"marketCap":765250767},{"date":"2024-10-04","current":-4.370937,"twenty":-8.98745,"median":-4.838029,"eighty":-1.655172,"marketCap":691831874},{"date":"2024-10-11","current":-4.567183,"twenty":-8.971724,"median":-4.830974,"eighty":-1.658751,"marketCap":722893713},{"date":"2024-10-18","current":-4.995356,"twenty":-8.948135,"median":-4.838029,"eighty":-1.658751,"marketCap":790664999},{"date":"2024-10-25","current":-4.602864,"twenty":-8.924007,"median":-4.83641,"eighty":-1.661465,"marketCap":728541321},{"date":"2024-10-31","current":-4.816951,"twenty":-8.892986,"median":-4.834791,"eighty":-1.664375,"marketCap":762426963},{"date":"2024-11-08","current":-5.548414,"twenty":-8.885231,"median":-4.841342,"eighty":-1.665125,"marketCap":878202910},{"date":"2024-11-15","current":-4.99289,"twenty":-8.878941,"median":-4.852632,"eighty":-1.665131,"marketCap":794463662},{"date":"2024-11-22","current":-4.619756,"twenty":-8.871078,"median":-4.850744,"eighty":-1.665131,"marketCap":735090933},{"date":"2024-11-29","current":-5.081731,"twenty":-8.860069,"median":-4.852632,"eighty":-1.666708,"marketCap":808600026},{"date":"2024-12-06","current":-5.152805,"twenty":-8.849061,"median":-4.870472,"eighty":-1.67001,"marketCap":819909117},{"date":"2024-12-13","current":-4.673061,"twenty":-8.805683,"median":-4.875862,"eighty":-1.67151,"marketCap":743572751},{"date":"2024-12-20","current":-4.353231,"twenty":-8.771915,"median":-4.861552,"eighty":-1.673035,"marketCap":692681840},{"date":"2024-12-27","current":-4.655292,"twenty":-8.76414,"median":-4.851688,"eighty":-1.674253,"marketCap":740745478},{"date":"2025-01-03","current":-4.797439,"twenty":-8.753132,"median":-4.841342,"eighty":-1.675222,"marketCap":763363661},{"date":"2025-01-10","current":-4.88628,"twenty":-8.72797,"median":-4.846043,"eighty":-1.67789,"marketCap":777500025},{"date":"2025-01-17","current":-3.304902,"twenty":-8.688655,"median":-4.838029,"eighty":-1.67789,"marketCap":525872744},{"date":"2025-01-24","current":-3.53589,"twenty":-8.682365,"median":-4.834791,"eighty":-1.67789,"marketCap":562627291},{"date":"2025-01-31","current":-3.340439,"twenty":-8.661921,"median":-4.811887,"eighty":-1.679855,"marketCap":531527290},{"date":"2025-02-07","current":-2.967305,"twenty":-8.640861,"median":-4.798193,"eighty":-1.68538,"marketCap":472154560},{"date":"2025-02-14","current":-2.896232,"twenty":-8.627956,"median":-4.793501,"eighty":-1.686639,"marketCap":460845469},{"date":"2025-02-21","current":-2.594171,"twenty":-8.614537,"median":-4.781102,"eighty":-1.68787,"marketCap":412781831},{"date":"2025-02-28","current":-2.29211,"twenty":-8.58329,"median":-4.769876,"eighty":-1.689866,"marketCap":364718193},{"date":"2025-03-07","current":-2.523097,"twenty":-8.555558,"median":-4.754922,"eighty":-1.692019,"marketCap":401472740},{"date":"2025-03-14","current":-2.611939,"twenty":-8.547326,"median":-4.744134,"eighty":-1.692932,"marketCap":415609104},{"date":"2025-03-21","current":-2.588533,"twenty":-8.5296,"median":-4.729232,"eighty":-1.69493,"marketCap":418436377},{"date":"2025-03-28","current":-2.716127,"twenty":-8.506035,"median":-4.709907,"eighty":-1.698123,"marketCap":439061859},{"date":"2025-04-04","current":-2.120331,"twenty":-8.444626,"median":-4.688325,"eighty":-1.703057,"marketCap":342751516},{"date":"2025-04-11","current":-1.866242,"twenty":-8.397503,"median":-4.683933,"eighty":-1.705519,"marketCap":301677987},{"date":"2025-04-17","current":-2.050237,"twenty":-8.381656,"median":-4.677375,"eighty":-1.705519,"marketCap":331420887},{"date":"2025-04-25","current":-2.453276,"twenty":-8.311308,"median":-4.670903,"eighty":-1.705519,"marketCap":396572002},{"date":"2025-05-02","current":-2.610986,"twenty":-8.214934,"median":-4.662447,"eighty":-1.707227,"marketCap":422065916},{"date":"2025-05-09","current":-2.435752,"twenty":-8.199925,"median":-4.654249,"eighty":-1.710599,"marketCap":393739345},{"date":"2025-05-16","current":-2.282851,"twenty":-8.195439,"median":-4.642856,"eighty":-1.712497,"marketCap":359774975},{"date":"2025-05-23","current":-2.174999,"twenty":-8.187108,"median":-4.635003,"eighty":-1.715357,"marketCap":342777732},{"date":"2025-05-30","current":-2.606404,"twenty":-8.180694,"median":-4.625165,"eighty":-1.719319,"marketCap":410766703},{"date":"2025-06-06","current":-2.822107,"twenty":-8.161451,"median":-4.620705,"eighty":-1.724217,"marketCap":444761189},{"date":"2025-06-13","current":-2.750206,"twenty":-8.090043,"median":-4.613342,"eighty":-1.725595,"marketCap":433429694},{"date":"2025-06-20","current":-2.516528,"twenty":-8.082119,"median":-4.602864,"eighty":-1.730373,"marketCap":396602334},{"date":"2025-06-27","current":-2.264875,"twenty":-8.072215,"median":-4.577102,"eighty":-1.730693,"marketCap":356942101},{"date":"2025-07-03","current":-2.588429,"twenty":-8.039123,"median":-4.566451,"eighty":-1.735399,"marketCap":407933830},{"date":"2025-07-11","current":-2.732231,"twenty":-8.024324,"median":-4.560794,"eighty":-1.736785,"marketCap":430596820},{"date":"2025-07-18","current":-2.678305,"twenty":-8.006845,"median":-4.531502,"eighty":-1.736956,"marketCap":422098199},{"date":"2025-07-25","current":-3.073759,"twenty":-7.971189,"median":-4.522662,"eighty":-1.736986,"marketCap":484421423},{"date":"2025-08-01","current":-2.543491,"twenty":-7.958026,"median":-4.513146,"eighty":-1.736986,"marketCap":400851645},{"date":"2025-08-08","current":-2.624379,"twenty":-7.930536,"median":-4.495821,"eighty":-1.738084,"marketCap":413599577},{"date":"2025-08-15","current":-3.471715,"twenty":-7.899945,"median":-4.479254,"eighty":-1.741893,"marketCap":445330718},{"date":"2025-08-22","current":-3.317159,"twenty":-7.862239,"median":-4.458676,"eighty":-1.743179,"marketCap":425505208},{"date":"2025-08-29","current":-3.471959,"twenty":-7.838468,"median":-4.40315,"eighty":-1.748314,"marketCap":445362118},{"date":"2025-09-05","current":-3.27293,"twenty":-7.834506,"median":-4.38313,"eighty":-1.750294,"marketCap":419831805},{"date":"2025-09-12","current":-3.560417,"twenty":-7.79501,"median":-4.366089,"eighty":-1.753419,"marketCap":456708923},{"date":"2025-09-19","current":-4.135391,"twenty":-7.746876,"median":-4.353231,"eighty":-1.755593,"marketCap":530463159},{"date":"2025-09-26","current":-4.002705,"twenty":-7.728964,"median":-4.34879,"eighty":-1.759643,"marketCap":513442951},{"date":"2025-10-03","current":-4.710365,"twenty":-7.666972,"median":-4.353231,"eighty":-1.763554,"marketCap":604217396},{"date":"2025-10-10","current":-5.418026,"twenty":-7.583315,"median":-4.366089,"eighty":-1.766345,"marketCap":694991840},{"date":"2025-10-17","current":-5.594941,"twenty":-7.538116,"median":-4.38313,"eighty":-1.768107,"marketCap":717685451},{"date":"2025-10-24","current":-4.88728,"twenty":-7.516465,"median":-4.413728,"eighty":-1.771654,"marketCap":626911007},{"date":"2025-10-31","current":-5.44014,"twenty":-7.477216,"median":-4.459841,"eighty":-1.774881,"marketCap":697828541},{"date":"2025-11-07","current":-4.953624,"twenty":-7.43099,"median":-4.48469,"eighty":-1.775609,"marketCap":635421111},{"date":"2025-11-14","current":-5.61788,"twenty":-7.404493,"median":-4.495821,"eighty":-1.778868,"marketCap":720627984},{"date":"2025-11-21","current":-6.177019,"twenty":-7.392985,"median":-4.513146,"eighty":-1.781506,"marketCap":788718817},{"date":"2025-11-28","current":-7.043579,"twenty":-7.381415,"median":-4.522662,"eighty":-1.783962,"marketCap":899366421},{"date":"2025-12-05","current":-7.088018,"twenty":-7.367409,"median":-4.531502,"eighty":-1.787242,"marketCap":905040657},{"date":"2025-12-12","current":-7.510188,"twenty":-7.381415,"median":-4.560794,"eighty":-1.791839,"marketCap":958945900},{"date":"2025-12-19","current":-7.999017,"twenty":-7.442087,"median":-4.566451,"eighty":-1.803558,"marketCap":1021362498},{"date":"2025-12-26","current":-7.621286,"twenty":-7.524009,"median":-4.577102,"eighty":-1.811,"marketCap":973131491},{"date":"2026-01-02","current":-8.265651,"twenty":-7.621286,"median":-4.599793,"eighty":-1.811,"marketCap":1055407914},{"date":"2026-01-09","current":-12.909525,"twenty":-7.687944,"median":-4.606291,"eighty":-1.812351,"marketCap":1648365587},{"date":"2026-01-16","current":-21.241834,"twenty":-7.754603,"median":-4.619756,"eighty":-1.812859,"marketCap":2712284855},{"date":"2026-01-23","current":-24.677094,"twenty":-7.834506,"median":-4.620705,"eighty":-1.817613,"marketCap":3150919473},{"date":"2026-01-30","current":-24.997572,"twenty":-7.899945,"median":-4.630543,"eighty":-1.818801,"marketCap":3191839959},{"date":"2026-02-06","current":-28.804186,"twenty":-7.981242,"median":-4.638545,"eighty":-1.827445,"marketCap":3677891243},{"date":"2026-02-13","current":-29.846761,"twenty":-8.024324,"median":-4.652346,"eighty":-1.831032,"marketCap":3811013569},{"date":"2026-02-20","current":-30.040729,"twenty":-8.076177,"median":-4.655292,"eighty":-1.83404,"marketCap":3835780513},{"date":"2026-02-27","current":-32.901751,"twenty":-8.137592,"median":-4.662447,"eighty":-1.836932,"marketCap":4201092943},{"date":"2026-03-06","current":-37.678202,"twenty":-8.1994,"median":-4.670903,"eighty":-1.841457,"marketCap":4810978949},{"date":"2026-03-13","current":-35.659457,"twenty":-8.377555,"median":-4.677375,"eighty":-1.851505,"marketCap":4553213363},{"date":"2026-03-20","current":-38.080718,"twenty":-8.5296,"median":-4.683933,"eighty":-1.856547,"marketCap":4742801087},{"date":"2026-03-25","current":-36.608397,"twenty":-8.563481,"median":-4.685822,"eighty":-1.856746,"marketCap":4559429354}],"updateTime":1774570199417},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ERAS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618930676","title":"Erasca Inc - Initial Phase 1 Monotherapy Data for Eras-0015 Expected in H1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618930676","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618930676?lang=en_us&edition=fundamental","pubTime":"2026-03-10 20:08","pubTimestamp":1773144522,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY11E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","ERAS"],"gpt_icon":0},{"id":"2618306799","title":"Erasca Inc - Exercises Option to Secure Worldwide Rights for Eras-0015","url":"https://stock-news.laohu8.com/highlight/detail?id=2618306799","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618306799?lang=en_us&edition=fundamental","pubTime":"2026-03-10 20:08","pubTimestamp":1773144522,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY11E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","ERAS"],"gpt_icon":0},{"id":"2618930567","title":"Erasca expands ERAS-0015 license to secure worldwide rights including China, Hong Kong and Macau","url":"https://stock-news.laohu8.com/highlight/detail?id=2618930567","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618930567?lang=en_us&edition=fundamental","pubTime":"2026-03-10 20:04","pubTimestamp":1773144257,"startTime":"0","endTime":"0","summary":"Erasca exercised its option to expand its ERAS-0015 license with Joyo to include China, Hong Kong and Macau, giving Erasca worldwide rights to the pan-RAS molecular glue. ERAS-0015 is being evaluated in the AURORAS-1 Phase 1 dose-escalation trial, with initial monotherapy data expected in the first half of 2026. In preclinical comparisons versus RMC-6236, ERAS-0015 showed about 8–21x higher binding affinity to cyclophilin A and about 5x greater potency in RAS inhibition. Preclinical results also indicated comparable or greater tumor growth inhibition or regression at doses about one-tenth to one-fifth of the dose of RMC-6236. Early Phase 1 dose-escalation data included confirmed and unconfirmed partial responses at doses as low as 8 mg once daily.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nNDL2j8G4h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BGHQF748.EUR","LU2210149790.SGD","SG9999014005.SGD","IE00BKPKM429.USD","LU2095319765.USD","BK4539","BK4585","SG9999014039.USD","NDAQ","SG9999014021.USD","BK4139","LU2210150020.SGD","SG9999014013.SGD","ERAS","LU0314104364.USD","IE00B3QW5Z07.USD","BK4112","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2617334846","title":"Erasca Chief Medical Officer Morris Shannon Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2617334846","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617334846?lang=en_us&edition=fundamental","pubTime":"2026-03-06 22:00","pubTimestamp":1772805653,"startTime":"0","endTime":"0","summary":"Morris Shannon, Chief Medical Officer of Erasca, Inc., reported a disposal of the company’s common shares. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Erasca Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDLcfVLXf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Erasca Chief Medical Officer Morris Shannon Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ERAS","BK4539"],"gpt_icon":0},{"id":"2617890436","title":"Erasca Is Maintained at Buy by Clear Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2617890436","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617890436?lang=en_us&edition=fundamental","pubTime":"2026-03-06 18:20","pubTimestamp":1772792400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ERAS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 06, 2026 05:20 ET (10:20 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERAS"],"gpt_icon":0},{"id":"2617757454","title":"Erasca price target raised to $20 from $11 at Clear Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2617757454","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617757454?lang=en_us&edition=fundamental","pubTime":"2026-03-06 06:20","pubTimestamp":1772749248,"startTime":"0","endTime":"0","summary":"Clear Street raised the firm’s price target on Erasca (ERAS) to $20 from $11 and keeps a Buy rating on the shares. The company announced a clinical...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/erasca-price-target-raised-to-20-from-11-at-clear-street-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/erasca-price-target-raised-to-20-from-11-at-clear-street-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ERAS"],"gpt_icon":0},{"id":"2617276735","title":"These stocks are set for high-stakes earnings moves. Here's your trading playbook.","url":"https://stock-news.laohu8.com/highlight/detail?id=2617276735","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617276735?lang=en_us&edition=fundamental","pubTime":"2026-03-06 01:52","pubTimestamp":1772733120,"startTime":"0","endTime":"0","summary":"S&P 500 remains stuck in a range - despite the bears' best efforts to swipe it down. Tech giant Oracle's latest earnings report will be closely watched.The number of companies reporting earnings is decreasing, but several upcoming announcements are sure to command investors' attention - especially tech giant Oracle .Traders will recall that Oracle's earnings report last September created a massive updraft of more than 100 points in the stock - which it quickly gave back and then some.Currently, the March 13 at-the-money straddle is priced at about 12% of Oracle's stock price. That's a bit expensive. Note the ORCL entry in the table below, where the \"count\" shows 11.74%. Six of the past 10 earnings moves for ORCL have been 11.74% or greater. So we'd like to be able to buy the straddle for that price just before earnings are announced - that is, buy late in the trading day on March 10.One more item of note: The past two quarters, Kohl's  has seen post-earnings moves, respectively, of +42","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USMV","ARKK","LU1989772923.USD","VVIX","VXX","VXZ","ORCX","VXMmain","IE00B3S45H60.SGD","ORCL","VIXmain","UPRO","ORCS","VIXY","ESmain","ULTA","SVOL","MESmain","SPYI","BK4214","KSS","SSO","SDS","TSEM","AAL","TVIXF","SVXY","ORCU","ERAS","OEX","LU0433182093.SGD","OEF",".SPX","IVV","LH","UVXY","KMX","LU0210536198.USD","SH","AALG","TVIX","VYLD","SVIX","VIXM","SPXU","BMO","SPY","BKR"],"gpt_icon":1},{"id":"2617542120","title":"Erasca, Tango Therapeutics Partner on Phase 1/2 Trial for Combination Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2617542120","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617542120?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:43","pubTimestamp":1772714585,"startTime":"0","endTime":"0","summary":"Erasca  said Thursday that it has entered into a clinical trial collaboration and supply agreement with Tango Therapeutics  to evaluate its experimental drug, ERAS-0015, in combination with Tango's vopimetostat.The company said the agreement would support phase 1/2 trial, which will target patients with a type of pancreatic cancer or non-small cell lung cancer.Erasca said that, as part of the agreement, it will supply ERAS-0015 free of charge, while Tango will serve as the trial sponsor.Both companies will retain commercial rights to their respective compounds, and the agreement is mutually non-exclusive, Erasca said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4583","TNXP","LENZ","BK4007","TNGX","ERAS","BK4539"],"gpt_icon":0},{"id":"2617541001","title":"Tango Therapeutics Q4 net loss widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2617541001","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617541001?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:11","pubTimestamp":1772712696,"startTime":"0","endTime":"0","summary":"Tango Therapeutics Q4 net loss widensOverviewBiotechnology firm reported Q4 net loss of $38.7 mln vs $30.8 mln loss a year ago; no collaboration revenueCompany holds $343 mln cash, funding operations ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nL1N3ZT0KO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERAS","TNGX","BK4539","BK4139"],"gpt_icon":0},{"id":"2617541108","title":"BRIEF-Erasca And Tango Therapeutics Enter Into Clinical Collaboration To Evaluate Combination Of ERAS-0015 And Vopimetostat","url":"https://stock-news.laohu8.com/highlight/detail?id=2617541108","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617541108?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:02","pubTimestamp":1772712160,"startTime":"0","endTime":"0","summary":"BRIEF-Erasca And Tango Therapeutics Enter Into Clinical Collaboration To Evaluate Combination Of ERAS-0015 And VopimetostatMarch 5 (Reuters) - Erasca Inc ERAS.O:ERASCA AND TANGO THERAPEUTICS ENTER INT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nFWN3ZT0S8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TNGX","BK4539","ERAS"],"gpt_icon":0},{"id":"2617541232","title":"Tango Therapeutics posts FY 2025 collaboration revenue of USD 62.4 million +108.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617541232","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617541232?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:01","pubTimestamp":1772712112,"startTime":"0","endTime":"0","summary":"Tango Therapeutics posts FY 2025 collaboration revenue of USD 62.4 million +108.2%               Tango Therapeutics posted a Q4 2025 net loss of USD 38.7 million, or USD 0.29 per share, and a FY 2025 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDLb8fTRl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2112291526.USD","LU0823416689.USD","LU1037948541.HKD","LU2324357040.USD","TNGX","BK4578","IE00BKVL7J92.USD","SG9999014021.USD","LU0965508806.USD","LU2210149790.SGD","LU0320765992.SGD","LU1674673428.USD","IE00B19Z3B42.SGD","IE0002270589.USD","SG9999015978.USD","LU1430594728.SGD","LU2468319806.SGD","LU0965509283.SGD","ERAS","LU0114720955.EUR","RVMD","NDAQ","IE00BGHQF748.EUR","IE00B7SZLL34.SGD","BK4139","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU2089984988.USD","LU0861579265.USD","BK4539","LU1674673691.USD","BK4585","LU0289739699.SGD","SG9999015952.SGD","LU1934455277.USD","LU1585245621.USD","BK4550","BK4532","LU1023059063.AUD","LU0965509101.SGD","LU2087621335.USD","LU1061106388.HKD","BK4566","LU1778281490.HKD","SG9999014013.SGD","BK4568","GILD","IE00B19Z3581.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"2617577541","title":"Erasca Inc: Co Will Supply Eras-0015 Free of Charge, and Tango Will Be Trial Sponsor","url":"https://stock-news.laohu8.com/highlight/detail?id=2617577541","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617577541?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:01","pubTimestamp":1772712072,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nFWN3ZT0S8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ERAS","BK4539","TNGX","BK4139"],"gpt_icon":0},{"id":"2617541685","title":"Erasca Inc: Each Company Will Retain Commercial Rights to Their Respective Compound","url":"https://stock-news.laohu8.com/highlight/detail?id=2617541685","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617541685?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:01","pubTimestamp":1772712072,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nFWN3ZT0S8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ERAS","TNGX","BK4139","BK4539"],"gpt_icon":0},{"id":"2617541656","title":"Erasca and Tango Therapeutics Enter Into Clinical Collaboration to Evaluate Combination of Eras-0015 and Vopimetostat","url":"https://stock-news.laohu8.com/highlight/detail?id=2617541656","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617541656?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:01","pubTimestamp":1772712072,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nFWN3ZT0S8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ERAS","TNGX","BK4539","BK4139"],"gpt_icon":0},{"id":"2613710104","title":"Erasca Granted US Patent for Investigational Drug ERAS-4001 to Treat Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2613710104","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613710104?lang=en_us&edition=fundamental","pubTime":"2026-02-24 22:39","pubTimestamp":1771943957,"startTime":"0","endTime":"0","summary":"Erasca  said Tuesday that the US Patent and Trademark Office has issued a patent covering the composition of matter for Erasca's investigational drug ERAS-4001 to treat patients with KRAS-mutant solid tumors.The patent, which is effective until June 2043, is titled \"Heterocyclic Substituted Pyrimidopyran Compound And Use Thereof,\" and also includes related compositions.\"With patent protection extending through at least 2043, the ERAS-4001 program is supported by a robust, long-term IP foundation, with additional patents pending,\" Erasca quoted its chief executive officer, Jonathan Lim, as saying in a statement. \"We look forward to reporting Phase 1 data for ERAS-0015 in the first half of the year and for ERAS-4001 in the second half of the year.\"","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ERAS","BK4539","BK4139"],"gpt_icon":0},{"id":"2613714679","title":"Erasca announces issuance of U.S. patent covering ERAS-4001","url":"https://stock-news.laohu8.com/highlight/detail?id=2613714679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613714679?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:11","pubTimestamp":1771938711,"startTime":"0","endTime":"0","summary":"Erasca (ERAS) announced that the U.S. Patent and Trademark Office has issued Patent No. 12,552,813, titled “Heterocyclic Substituted Pyrimidopyran ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/erasca-announces-issuance-of-u-s-patent-covering-eras-4001-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/erasca-announces-issuance-of-u-s-patent-covering-eras-4001-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ERAS","BK4539","BK4139"],"gpt_icon":0},{"id":"2613711431","title":"Erasca Wins U.S. Patent for Pan-KRAS Inhibitor ERAS-4001 Through at Least 2043","url":"https://stock-news.laohu8.com/highlight/detail?id=2613711431","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613711431?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:01","pubTimestamp":1771938065,"startTime":"0","endTime":"0","summary":"Erasca Inc. said the U.S. Patent and Trademark Office issued U.S. Patent No. 12,552,813, titled “Heterocyclic Substituted Pyrimidopyran Compound And Use Thereof,” covering the composition of matter for its pan-KRAS inhibitor ERAS-4001 and related compositions. The company said the patent provides protection through at least June 2043, subject to possible term adjustments or extensions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL3HLg5p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","IE00B64PRP62.GBP","SG9999014005.SGD","LU2210150020.SGD","LU0314104364.USD","BK4539","BK4112","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4585","BK4588","SG9999014021.USD","NDAQ","LU2095319765.USD","ERAS","SG9999014039.USD","BK4139","IE00BKPKM429.USD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2613714289","title":"Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001","url":"https://stock-news.laohu8.com/highlight/detail?id=2613714289","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613714289?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:00","pubTimestamp":1771938000,"startTime":"0","endTime":"0","summary":"The issued patent provides intellectual property protection for ERAS-4001 and related compositions until at least 2043 Expands Erasca’s diversified IP portfolio for RAS-driven cancers Initial Phase 1 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243464/0/en/Erasca-Announces-Issuance-of-a-U-S-Patent-Covering-Pan-KRAS-Inhibitor-ERAS-4001.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1481600234.SGD","PK","BK4139","BK4136","BK4588","IP","LU1169590202.USD","LU2463526074.USD","IE00B3T34201.USD","ERAS","LU1487256676.USD","ADME","BK4539","BK4181","BK4218","LU1481599808.USD","LU1169589451.USD","BK4585"],"gpt_icon":0},{"id":"2609446308","title":"Erasca to Present at Upcoming Conferences in February","url":"https://stock-news.laohu8.com/highlight/detail?id=2609446308","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609446308?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:00","pubTimestamp":1770296400,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Feb.  05, 2026  (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/05/3232925/0/en/Erasca-to-Present-at-Upcoming-Conferences-in-February.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ERAS"],"gpt_icon":0},{"id":"2607020046","title":"Erasca CFO and CBO David M. Chacko Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2607020046","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607020046?lang=en_us&edition=fundamental","pubTime":"2026-01-30 22:04","pubTimestamp":1769781875,"startTime":"0","endTime":"0","summary":"David M. Chacko, Chief Financial Officer and Chief Business Officer of Erasca Inc., has reported the acquisition of common shares of Erasca Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Erasca Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL68YsCF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Erasca CFO and CBO David M. Chacko Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ERAS","BK4139","BK4539"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":105,"code":"91000000","status":"200"}]}}